AptarGroup ATR Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net Sales by Business | ||||||
| Beauty | $372.16M+19.2% | —— | —— | —— | $312.3M-0.3% | |
| Closures | $182.19M+4.8% | —— | —— | —— | $173.92M-3.6% | |
| Pharma | $438.91M+7.1% | —— | —— | —— | $409.7M-0.3% | |
| Total by Business | ||||||
| Beauty | $363.64M+18.9% | —— | —— | —— | $305.71M-0.2% | |
| Closures | $180.67M+5.0% | —— | —— | —— | $172.13M-3.6% | |
| Pharma | $438.56M+7.1% | —— | —— | —— | $409.47M-0.3% | |
| Other Segment Items: by Business | ||||||
| Beauty | -$965K+49.0% | —— | —— | —— | -$1.89M-201% | |
| Closures | $188K+135% | —— | —— | —— | -$532K-46.2% | |
| Pharma | -$4.32M-616% | —— | —— | —— | -$603K-106% | |
| Cost of Sales (exclusive of depreciation and amortization): by Business | ||||||
| Beauty | $271.49M+21.2% | —— | —— | —— | $224.05M+1.3% | |
| Closures | $131.88M+7.8% | —— | —— | —— | $122.39M-4.3% | |
| Pharma | $228.54M+11.4% | —— | —— | —— | $205.14M-1.7% | |
| Adjusted EBITDA by Business | ||||||
| Beauty | $40.48M+9.0% | —— | —— | —— | $37.14M-7.1% | |
| Closures | $23.66M-13.2% | —— | —— | —— | $27.26M-4.5% | |
| Pharma | $146.22M+2.6% | —— | —— | —— | $142.45M+0.3% | |
| Restructuring initiatives by Business | ||||||
| Beauty | $1.3M+229% | —— | —— | —— | $395K-80.4% | |
| Closures | $249K-81.6% | —— | —— | —— | $1.35M+41.0% | |
| Pharma | $5K-97.4% | —— | —— | —— | $190K+29.0% | |
| Selling, research & development and administrative by Business | ||||||
| Beauty | $52.63M+13.4% | —— | —— | —— | $46.41M+0.9% | |
| Closures | $24.95M+8.4% | —— | —— | —— | $23.01M+2.4% | |
| Pharma | $68.12M+9.0% | —— | —— | —— | $62.48M+3.6% | |
| Depreciation and Amortization by Business | ||||||
| Beauty | $24.72M+23.2% | —— | —— | —— | $20.06M-3.2% | |
| Closures | $14.22M+4.8% | —— | —— | —— | $13.58M-5.3% | |
| Pharma | $35.64M+14.4% | —— | —— | —— | $31.15M+3.5% | |
| Foreign currency exchange effects by Business | ||||||
| Beauty | -$690K-121% | $3.34M+330% | $3.34M+330% | $3.34M+330% | $3.34M+330% | |
| Closures | -$284K-171% | $402.75K+242% | $402.75K+242% | $402.75K+242% | $402.75K+242% | |
| Pharma | -$4.36M-143% | $10.27M+303% | $10.27M+303% | $10.27M+303% | $10.27M+303% | |
| Goodwill by Business | ||||||
| Beauty | $370.16M— | $370.85M+31.8% | —— | —— | —— | |
| Closures | $168.06M— | $168.35M+1.0% | —— | —— | —— | |
| Pharma | $534.34M— | $538.7M+10.3% | —— | —— | —— | |
| Capital Expenditures by Business | ||||||
| Beauty | $20.2M+25.1% | —— | —— | —— | $16.14M0.0% | |
| Closures | $13.74M+31.2% | —— | —— | —— | $10.47M-8.5% | |
| Pharma | $28.89M-1.9% | —— | —— | —— | $29.45M-20.5% | |
| Total by Geography | ||||||
| Asia | $106.25M+13.4% | $125.64M+32.9% | $120.47M+16.5% | $104.12M+12.8% | $93.69M+2.9% | |
| Domestic | $279.81M-0.9% | $282.37M-1.3% | $299.73M+2.8% | $309.75M+6.9% | $282.46M+1.6% | |
| Europe | $510.85M+16.5% | $482.12M+20.5% | $465.8M+4.6% | $476M+5.7% | $438.65M-7.5% | |
| Latin America | $85.97M+18.6% | $72.62M+8.1% | $75.13M+8.6% | $76.14M-2.1% | $72.51M+0.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does AptarGroup break its business down?
- AptarGroup (ATR) reports net sales by business across 3 parts — Beauty, Closures and Pharma. Each is extracted from the segment footnotes and tracked over time.
- Where does AptarGroup's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in AptarGroup's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
